ISRCTN65811336已完成2 期
Allopurinol in the prevention of superficial bladder tumour recurrence
eicester General Hospital (UK)0 个研究点目标入组 64 人开始时间: 2006年8月17日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with solitary Transitional Cell Carcinoma
- •(TCC) Ta or T1 bladder tumour (Grade one to two) that recurs at three months
- •2. Patients with multifocal TCC Ta bladder tumours (Grade one to two) that do not recur at three months
- •3. Patients with multifocal TCC Ta bladder tumours (Grade one to two) that recurs at three months
排除标准
- •1. Tumours with a higher risk of progression to muscle-invasive bladder cancer
- •2. Non-TCC bladder cancer
- •3. Multifocal T1 or Grade three TCC
- •4. Carcinoma in situ
- •5. More than one instillation of intravesical chemotherapy
- •6. Intravesical Bacillus Calmette-Guerin (BCG) therapy
- •Other reasons:
- •1. Current azathioprine or mercaptopurine treatment
- •2. Serum creatinine more than 200 µmol/l
- •3. Pregnant
- •4. Breast feeding
- •5. Aged under 18 year of age
- •6. Previous Allopurinol hypersensitivity
- •7. Current allopurinol treatment
研究者
相似试验
进行中（未招募）
不适用
Allopurinol in the prevention of superficial bladder tumour recurrence - RAPOR studySuperficial Bladder Cancer - Role of allopurinol in prevention of tumour recurrenceEUCTR2005-003219-66-GBuniversity Hospitals of Leicester NHS Trust60
已完成
3 期
The effect of Allopurinol in prevention of contrast induced nephropathy in patients undergoing angioplastyephropathy.Disorder of kidney and ureter, unspecified28.9IRCT20190406043182N1Tabriz University of Medical Sciences100
已完成
2 期
Allopurinol in the prevention of pre-procedural myocardial injury following angioplastyIschemic heart diseases patients.Ischaemic heart diseasesI20, I21,IRCT201412088307N11Vice chancellor for research, Tabriz University of Medical Sciences100
Enrolling By Invitation
3 期
Prucalopride for minimizing bowel ileus following ERCP with CO2 insufflation: A prospective randomize double-blinded placebo controlled trialMust have provided written informed consent prior to any screening procedures.Male/female patients between 18 to 65 years of age at the time of informed consent who visit the clinic for having ERCP procedure.ERCPTCTR20210814001Srinagarind Hospital Khonkaen University194
已完成
不适用
Effect of allopurinol in preventing kidney damage due to coronary angiographycontrast induced nephropathy.X-ray contrast mediaIRCT2015120525372N1Tehran University of Medical Sciences200